# Via, a Hyaluronic Acid (HLA) Based Vaginal Moisturizer Study

> **NCT07038070** · NA · WITHDRAWN · sponsor: **NYU Langone Health**

## Conditions studied

- Genitourinary Syndrome of Menopause (GSM)

## Interventions

- **DRUG:** Vaginal estrogen tablet
- **DEVICE:** Via Solv Wellness (Hyaluronic Acid Therapy)

## Key facts

- **NCT ID:** NCT07038070
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-07-01
- **Primary completion:** 2026-05-01
- **Final completion:** 2026-05-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was placed on hold by the Sponsor for \~1 year. Given the prolonged hold and absence of participant activity, the study was closed.
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07038070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07038070, "Via, a Hyaluronic Acid (HLA) Based Vaginal Moisturizer Study". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT07038070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*